Table 3.
Unadjusted and multivariable analyses of Hgb parameters
| Unadjusted | Adjusted for other Hgb parametersa | Adjusted for other Hgb parameters and demographicsb | Adjusted for other Hgb parameters, demographics, and comorbiditiesc | Adjusted for other Hgb parameters, demographics, comorbidities, amd labsd | Adjusted for other Hgb parameters, demographics, comorbidities, labs, and medicationse | |
|---|---|---|---|---|---|---|
| Hgb-Var (per g/dl) | 0.96 (0.81–1.14) | 1.03 (0.87–1.23) | 1.04 (0.87–1.24) | 1.06 (0.89–1.27) | 1.07 (0.89–1.30) | 1.11 (0.92–1.33) |
| Mean Hgb (per g/dl) | 0.72 (0.65–0.79) | 0.73 (0.66–0.80) | 0.69 (0.62–0.75) | 0.70 (0.63–0.77) | 0.78 (0.71–0.86) | 0.76 (0.68–0.86) |
| Hgb slope (per g/dl per month) | 0.66 (0.53–0.82) | 0.71 (0.57–0.88) | 0.83 (0.66–1.04) | 0.86 (0.68–1.08) | 0.93 (0.74–1.18) | 0.97 (0.75–1.24) |
a
Other variables in the table.
b
Age, sex, race (white, nonwhite, unknown), BMI (≤ 20, 20–25, 25–30, 30–35, >35 kg/m2).
c
Diabetes, hypertension, arterial disease (coronary and/or cerebrovascular and/or peripheral vascular disease), cancer, and congestive heart failure.
d
Serum creatinine, phosphate, albumin, and ekT/V averaged over days 90 to 180.
e
Cumulative 6-month intravenous iron and erythropoietin doses.